Abstract
Aspartimide (Asi) formation is one of the most serious side reactions that can occur both during solid phase synthesis and storage of peptides containing aspartic acid. Although numerous studies on the mechanism of Asi formation conducted so far, the problem still remains unresolved and relatively little is known about the impact of this side reaction on biological properties of such modified peptides. In the present work we characterized the effect of Asi formation on biological properties of galanin(1-15) analogue modified in position 14 with aspartic acid, investigating its action on rat isolated gastric smooth muscles and glucose-induced insulin secretion from rat isolated islets of Langerhans. Our results show that this side process may adversely affect biological properties of such modified peptides. As we expected, modification of GAL(1-15)NH2 structure changed the interaction of GAL(1-15)NH2 with its receptors and consequently yielded peptide which, in studies on insulin secretion, showed insulinotropic- and antagonistic activities as compared to Asi-free analogue.
Keywords: Aspartimide, galanin analogue, insulin secretion, smooth muscle
Protein & Peptide Letters
Title: Aspartimide Modified Galanin Analogue Antagonizes Galanin Action on Insulin Secretion
Volume: 17 Issue: 10
Author(s): Jaroslaw Ruczynski, Zdzislaw Konstanski, Magdalena Cybal, Ivan Kocic and Piotr Rekowski
Affiliation:
Keywords: Aspartimide, galanin analogue, insulin secretion, smooth muscle
Abstract: Aspartimide (Asi) formation is one of the most serious side reactions that can occur both during solid phase synthesis and storage of peptides containing aspartic acid. Although numerous studies on the mechanism of Asi formation conducted so far, the problem still remains unresolved and relatively little is known about the impact of this side reaction on biological properties of such modified peptides. In the present work we characterized the effect of Asi formation on biological properties of galanin(1-15) analogue modified in position 14 with aspartic acid, investigating its action on rat isolated gastric smooth muscles and glucose-induced insulin secretion from rat isolated islets of Langerhans. Our results show that this side process may adversely affect biological properties of such modified peptides. As we expected, modification of GAL(1-15)NH2 structure changed the interaction of GAL(1-15)NH2 with its receptors and consequently yielded peptide which, in studies on insulin secretion, showed insulinotropic- and antagonistic activities as compared to Asi-free analogue.
Export Options
About this article
Cite this article as:
Ruczynski Jaroslaw, Konstanski Zdzislaw, Cybal Magdalena, Kocic Ivan and Rekowski Piotr, Aspartimide Modified Galanin Analogue Antagonizes Galanin Action on Insulin Secretion, Protein & Peptide Letters 2010; 17 (10) . https://dx.doi.org/10.2174/092986610792231447
DOI https://dx.doi.org/10.2174/092986610792231447 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Current Pharmaceutical Design Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis
Current Pharmaceutical Design Conference Report: The Myriad Pathways of Neurodegeneration Discussed at NEUROCON 2015
Current Aging Science Neurohypophyseal Dysfunction During Septic Shock
Endocrine, Metabolic & Immune Disorders - Drug Targets Release of Adenosine and ATP During Ischemia and Epilepsy
Current Neuropharmacology Animal Models of Narcolepsy
CNS & Neurological Disorders - Drug Targets Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis
Current Medicinal Chemistry Brain Tumor Causes, Symptoms, Diagnosis and Radiotherapy Treatment
Current Medical Imaging The Control of Male Sexual Responses
Current Pharmaceutical Design Chronic Stress Impacts on Olfactory System
CNS & Neurological Disorders - Drug Targets Diagnosis and Treatment of Common Sleep Disorders in Adolescence
Adolescent Psychiatry Subject Index to Volume 5
Current Drug Targets Insulin and the Future Treatment of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Leptin in Thrombosis and Atherosclerosis
Current Pharmaceutical Design Exposure to Enriched Environment Restores the mRNA Expression of Mineralocorticoid and Glucocorticoid Receptors in the Hippocampus and Ameliorates Depressive-like Symptoms in Chronically Stressed Rats
Current Neurovascular Research Medications Acting on the GABA System in the Treatment of Alcoholic Patients
Current Pharmaceutical Design Neurologic Sequelae in Critical Illness: Evaluation and Outcomes
Current Respiratory Medicine Reviews The Relaxin Peptide Family – Structure, Function and Clinical Applications
Protein & Peptide Letters TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
Current Drug Targets Editorial (Thematic Issue: Cocaine and Amphetamine-Type Stimulants: the Search for Pharmacological Therapies)
Current Pharmaceutical Design